MX2015010102A - Vacuna de subunidades anti-mycoplasma spp. - Google Patents

Vacuna de subunidades anti-mycoplasma spp.

Info

Publication number
MX2015010102A
MX2015010102A MX2015010102A MX2015010102A MX2015010102A MX 2015010102 A MX2015010102 A MX 2015010102A MX 2015010102 A MX2015010102 A MX 2015010102A MX 2015010102 A MX2015010102 A MX 2015010102A MX 2015010102 A MX2015010102 A MX 2015010102A
Authority
MX
Mexico
Prior art keywords
mycoplasma spp
vaccine
proteins
subunit vaccine
active ingredient
Prior art date
Application number
MX2015010102A
Other languages
English (en)
Other versions
MX355078B (es
Inventor
Jiunn-Horng Lin
Jyh-Perng Wang
Ming-Wei Hsieh
Zeng-Weng Chen
Chien-Yu Fang
Hsueh-Tao Liu
Ping-Cheng Yang
Original Assignee
Agricultural Technology Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Technology Res Inst filed Critical Agricultural Technology Res Inst
Publication of MX2015010102A publication Critical patent/MX2015010102A/es
Publication of MX355078B publication Critical patent/MX355078B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proveen en la presente invención vacunas de subunidades antí-Mycoplasma spp., especialmente proteínas adecuadas para que sean usadas como el ingrediente activo de las vacunas de subunidades de Mycoplasma spp., y una vacuna preparada de las mismas; tras la experimentación, se confirma que las proteínas pueden inducir una respuesta inmune que tiene resistencia suficiente para evitar la infección por Mycoplasma spp. en cerdos; la vacuna puede comprender una de las proteínas mencionadas anteriormente como un ingrediente activo, o puede comprender dos o más de las proteínas para formar una forma de vacuna coctel; la vacuna de la presente invención no es sólo más segura que las vacunas convencionales, sino tiene también efectos inmunes equivalentes o incluso mejores.
MX2015010102A 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp. MX355078B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/071379 WO2014121433A1 (zh) 2013-02-05 2013-02-05 抗霉浆菌的亚单位疫苗

Publications (2)

Publication Number Publication Date
MX2015010102A true MX2015010102A (es) 2016-04-27
MX355078B MX355078B (es) 2018-04-03

Family

ID=51299148

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015010102A MX355078B (es) 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp.
MX2017014670A MX370715B (es) 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017014670A MX370715B (es) 2013-02-05 2013-02-05 Vacuna de subunidades anti-mycoplasma spp.

Country Status (14)

Country Link
US (7) US9561267B2 (es)
EP (3) EP2955192B1 (es)
JP (1) JP6113306B2 (es)
KR (7) KR101773486B1 (es)
CN (1) CN104918953B (es)
BR (1) BR112015018444A2 (es)
DK (1) DK2955192T3 (es)
ES (1) ES2812552T3 (es)
MX (2) MX355078B (es)
PH (1) PH12015501716B1 (es)
RU (1) RU2636459C2 (es)
TW (1) TWI609878B (es)
UA (2) UA116431C2 (es)
WO (1) WO2014121433A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646137C2 (ru) * 2013-11-21 2018-03-01 Эгрикалчурал Текнолоджи Рисерч Инститьют КОМПОЗИЦИЯ ПО ПРЕДУПРЕЖДЕНИЮ ИНФЕКЦИИ Mycoplasma spp.
US9403941B2 (en) 2014-07-07 2016-08-02 Mast Therapeutics, Inc. Poloxamer composition free of long circulating material and methods for production and uses thereof
CN106139137A (zh) * 2015-03-30 2016-11-23 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
WO2017011919A1 (en) * 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma vaccines and uses thereof
ES2881625T3 (es) * 2015-12-28 2021-11-30 Agricultural Tech Res Inst Método de preparación de la proteína de la cápside del circovirus porcino tipo 2 y composición farmacéutica que la comprende
TWI606839B (zh) * 2016-08-09 2017-12-01 財團法人農業科技研究院 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
CN109476711B (zh) * 2016-08-09 2023-08-08 财团法人农业科技研究院 防治猪鼻霉浆菌感染的组合物及生产该组合物的方法
US11253581B2 (en) * 2017-11-01 2022-02-22 Agricultural Technology Research Institute Composition for preventing or treating Mycoplasma synoviae infection
RU2737971C1 (ru) * 2020-05-22 2020-12-07 Эгрикалчурал Текнолоджи Рисерч Инститьют Композиция для профилактики и лечения инфекции mycoplasma hyorhinis и способ получения указанной композиции

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE134705T1 (de) * 1988-06-29 1996-03-15 Ml Technology Ventures Rekombinantes hyopneumoniae antigen und dessen verwendung
EP0571648A1 (en) * 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
KR100262208B1 (ko) * 1992-05-29 2000-07-15 나카노 카쯔히코 가금 마이코플라스마 항원, 그의 유전자, 그 유전자를 함유한 재조합 벡터, 및 이를 이용한 백신
DE19816334A1 (de) 1998-04-11 1999-10-14 Krupp Uhde Gmbh Elektrolyseapparat zur Herstellung von Halogengasen
AU6128900A (en) 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6537552B1 (en) 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
KR20040030785A (ko) * 2001-07-02 2004-04-09 화이자 프로덕츠 인크. 마이코플라즈마 하이오뉴모니애로의 1회 투여량 예방접종
WO2005003313A2 (en) * 2003-06-26 2005-01-13 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
BR0306775A (pt) * 2003-12-23 2005-10-04 Conselho Nacional Cnpq Polinucleotìdeos codificadores de atividades do cromossomo da bactéria mycoplasma hyopneumoniae
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
US8034910B2 (en) 2008-05-06 2011-10-11 Academia Sinica, Taiwan SUMO fusion protein expression system for producing native proteins
JP2012518417A (ja) * 2009-02-20 2012-08-16 シーディージー セラピューティクス，インコーポレイテッド Ｐａ−ｃａｒｄを用いて癌を予防及び／又は治療するための組成物及び方法
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用

Also Published As

Publication number Publication date
EP2955192A4 (en) 2016-11-23
UA115348C2 (uk) 2017-10-25
US20170182142A1 (en) 2017-06-29
US20170151318A1 (en) 2017-06-01
KR20170082656A (ko) 2017-07-14
CN104918953A (zh) 2015-09-16
KR101773486B1 (ko) 2017-08-31
KR20170081758A (ko) 2017-07-12
RU2015137851A (ru) 2017-03-14
KR101838160B1 (ko) 2018-03-13
ES2812552T3 (es) 2021-03-17
US9730990B2 (en) 2017-08-15
KR20170081757A (ko) 2017-07-12
KR20150107767A (ko) 2015-09-23
RU2636459C2 (ru) 2017-11-23
EP2955192A1 (en) 2015-12-16
EP2955192B1 (en) 2020-07-01
KR101775434B1 (ko) 2017-09-06
MX370715B (es) 2019-12-20
BR112015018444A2 (pt) 2018-05-08
US9750791B2 (en) 2017-09-05
US9775893B2 (en) 2017-10-03
KR20170081760A (ko) 2017-07-12
TWI609878B (zh) 2018-01-01
US20170196959A1 (en) 2017-07-13
CN104918953B (zh) 2019-04-02
KR101758778B1 (ko) 2017-07-18
PH12015501716A1 (en) 2015-11-09
KR101775435B1 (ko) 2017-09-06
UA116431C2 (uk) 2018-03-12
US9757441B2 (en) 2017-09-12
DK2955192T3 (en) 2020-08-17
EP3733691A1 (en) 2020-11-04
JP6113306B2 (ja) 2017-04-12
PH12015501716B1 (en) 2015-11-09
US9750792B2 (en) 2017-09-05
KR20170082657A (ko) 2017-07-14
KR101764750B1 (ko) 2017-08-03
US9750790B2 (en) 2017-09-05
KR101831318B1 (ko) 2018-02-22
TW201431873A (zh) 2014-08-16
US20170182144A1 (en) 2017-06-29
MX355078B (es) 2018-04-03
WO2014121433A1 (zh) 2014-08-14
EP3733690A1 (en) 2020-11-04
JP2016514086A (ja) 2016-05-19
US20170202942A1 (en) 2017-07-20
US20150366959A1 (en) 2015-12-24
US20170182143A1 (en) 2017-06-29
US9561267B2 (en) 2017-02-07
KR20170081759A (ko) 2017-07-12

Similar Documents

Publication Publication Date Title
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
PH12018500127A1 (en) Vaccine compositions
PH12017502233A1 (en) Formulations for neoplasia vaccines and methods of preparing thereof
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MX2022002106A (es) Formulaciones de vacuna de vial unico.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
SG11202003800YA (en) Zika vaccines and immunogenic compositions, and methods of using the same
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
MX2021013109A (es) Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue.
SG11202004863QA (en) Zika vaccines and immunogenic compositions, and methods of using the same
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
PH12014501795A1 (en) Rota virus subunit vaccines and methods of making and use thereof
MX2016002823A (es) Metodos y composiciones para vacunas vectorizadas virales.
ZA201602148B (en) Immunogenic formulation containing recombinant live bcg that express antigens of metapneumovirus (hmpv), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use
EA201690378A1 (ru) Вакцинные композиции против наркотической зависимости
WO2013173256A3 (en) New and improved influenza vaccines
MX2019015700A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015698A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015697A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015696A (es) Vacuna de subunidades anti-mycoplasma spp.
MX2019015695A (es) Vacuna de subunidades anti-mycoplasma spp.

Legal Events

Date Code Title Description
FG Grant or registration